Leukemia in infants is rare but generates tremendous interest due to its aggressive clinical
presentation in a uniquely vulnerable host, its poor response to current therapies, and its …

Acute myeloid leukemia (AML) is the most common acute leukemia in adults and the second
most common frequent leukemia of childhood. Patients may present with lymphopenia or …

We evaluated the outcome of 482 children with acute myeloid leukemia (AML) enrolled in
the Associazione Italiana di Ematologia e Oncologia Pediatrica AML 2002/01 trial …

Cytogenetic abnormalities and early response to treatment are the main prognostic factors in
acute myeloid leukemia (AML). Recently, NUP98/NSD1 (t (5; 11)(q35; p15)), a …

Patients with core binding factor acute myeloid leukemia (CBF-AML) with translocation (8;
21)(q22; q22)[t (8; 21)] and inversion of chromosome 16 (p13. 1q22), or its variant t (16; …

Background The assessment of nutritional status among paediatric patients is important for
the planning and execution of nutritional strategies that strive to optimise the quality of life …

Abstract Infants (< 1 year old) with acute myeloid leukemia (AML) are particularly vulnerable
to intensive cytotoxic therapy. Indeed, the mortality rate was high among infants enrolled in …

BACKGROUND A retrospective meta‐analysis of adolescents and young adults (AYAs) with
acute myeloid leukemia (AML) was performed to determine if differences in outcome exist …

Background Osteonecrosis (ON) is a disabling complication of chemotherapy, especially
steroids in children and adolescents. There are few reports in the literature of non‐surgical …

Over the past 50 years, numerous advances in treatment have produced dramatic increases
in the cure rates of pediatric leukemias. Despite this progress, the majority of children with …